Trials / Completed
CompletedNCT01592162
Comparison of Different Propofol Formulations With or Without Remifentanil
Dose-effect of Propofol for Anesthetic Induction: Double-blind Comparison of Different Propofol Formulations Administered Alone or With Remifentanil
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 409 (actual)
- Sponsor
- Hopital Foch · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the influence of different propofol formulations (plain or with remifentanil) on anesthetic induction. Propofol plain or with remifentanil is administered using a closed-loop algorithm in order to reach a Bispectral Index target of 50.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Propofol (Astra-Zeneca), NaCl 0.9% | propofol administered by a closed-loop system and saline |
| DRUG | propofol 1% (Astra-Zeneca) and remifentanil | propofol administered by a closed-loop system and remifentanil (2 ng/ml, target controled infusion) |
| DRUG | propofol 1% (Astra-Zeneca) and remifentanil | propofol administered by a closed-loop system and remifentanil (4 ng/ml, target controled infusion) |
| DRUG | Propofol (Astra-Zeneca), NaCl 0.9% | propofol administered by a closed-loop system and saline |
| DRUG | Propofol (Astra-Zeneca) and remifentanil | propofol administered by a closed-loop system and remifentanil (2 ng/ml, target controled infusion) |
| DRUG | Propofol (Astra-Zeneca) and remifentanil | propofol administered by a closed-loop system and remifentanil (4 ng/ml, target controled infusion) |
| DRUG | Propofol (B-Braun) and NaCl 0.9% | propofol administered by a closed-loop system and saline |
| DRUG | Propofol (B-Braun) and remifentanil | propofol administered by a closed-loop system and remifentanil (2 ng/ml, target controled infusion) |
| DRUG | Propofol (B-Braun) and remifentanil | propofol administered by a closed-loop system and remifentanil (4 ng/ml, target controled infusion) |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2014-11-01
- Completion
- 2014-11-01
- First posted
- 2012-05-07
- Last updated
- 2016-11-03
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01592162. Inclusion in this directory is not an endorsement.